Company General Biologicals Corporation

Equities

4117

TW0004117007

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Taipei Exchange Other stock markets 03:30:00 13/05/2024 am IST			5-day change	1st Jan Change
19.65 ^TWD	-0.76%		-2.72%	-27.22%

30/04	General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	CI

GENERAL BIOLOGICALS CORP. is a Taiwan-based company principally engaged in the design, development, manufacture, sales and import and export trading of diagnostic kits and auxiliary equipment, as well as the provision of medical technology services. The Company's main products include detection reagents, biological protein new drug, P113, and medical supplies. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 81

TWD in Million	2022	Weight	2023	Weight	Delta
Medical Technology 57.7 %	151	40.8 %	153	57.7 %	+1.09%
Test Reagent 29.5 %	219	59.2 %	78	29.5 %	-64.41%
New Protein Drugs 12.8 %	-	-	34	12.8 %	-

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 66.0 %	229	61.8 %	175	66.0 %	-23.62%
North America 16.1 %	77	20.8 %	43	16.1 %	-44.64%
Asia 16.1 %	56	15.0 %	43	16.1 %	-23.23%
Africa 1.1 %	5	1.4 %	3	1.1 %	-46.31%
Europe 0.7 %	4	1.0 %	2	0.7 %	-49.71%

Managers	Title	Age	Since
Meng Te Lin CEO	Chief Executive Officer	-	15/13/15
En Jung Tsao DFI	Director of Finance/CFO	-	-
Meng Hui Lin PRN	Corporate Officer/Principal	-	01/13/01

Members of the board	Title	Age	Since
Ming-Chih Hsuan BRD	Director/Board Member	70	24/10/24
Tsung Ching Lin CHM	Chairman	-	25/89/25
Pi Hua Chen BRD	Director/Board Member	-	-
Che Jen Chuang BRD	Director/Board Member	-	15/13/15
Chien Ju Lin BRD	Director/Board Member	-	17/19/17
Meng Te Lin CEO	Chief Executive Officer	-	15/13/15
Hsiang Hui Kung BRD	Director/Board Member	-	15/07/15
Chia Shang Chen BRD	Director/Board Member	-	24/10/24
Meng Hui Lin PRN	Corporate Officer/Principal	-	01/13/01
Chin Lieh Wu BRD	Director/Board Member	-	17/19/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	59,825,000	59,824,370 ( 100.00 %)	0	100.00 %

General Biologicals Corp.

Science Based Park No. 6, Innovation First Road

300 76, Hsinchu

http://www.gbc.com.tw

address General Biologicals Corporation(4117)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GENERAL BIOLOGICALS CORPORATION	-27.22%	36.49M
BIOMÉRIEUX	-3.58%	12.64B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-1.48%	8.46B
DIASORIN S.P.A.	+8.70%	5.66B
LANTHEUS HOLDINGS, INC.	+25.61%	5.27B
AUTOBIO DIAGNOSTICS CO., LTD.	-4.58%	4.49B
10X GENOMICS, INC.	-51.80%	3.11B
ANDON HEALTH CO., LTD.	+16.25%	2.87B
MYRIAD GENETICS, INC.	+30.25%	2.31B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-4.08%	1.89B

Diagnostic & Testing Substances